Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher Scientific Inc. stock reports Q3 results pre-market

Published on 10/22/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The company supplies laboratory technologies and pharmaceutical services. At Lang & Schwarz the stock trades pre-market at EUR 618.70 on October 22, 2026.

Quarterly results and business focus

  • Thermo Fisher reported third-quarter results on October 21, 2026.
  • Revenue grew 9 percent to USD 12.14 billion in the quarter.
  • Thermo Fisher Scientific Inc. stock trades pre-market at EUR 618.70 at 8:12 a.m. CEST at Lang & Schwarz on October 22, 2026.
Pop-Art-Comic feiert Thermo Fisher Sci. US8835561023 mit farbenfrohem Wissenschaftler, Reagenzglas und knalligen Comic-Explosionslinien, Illustration mit AI erstellt.

Thermo Fisher Scientific Inc. reported third-quarter 2026 results on October 21, 2026, with revenue up 9 percent to USD 12.14 billion and adjusted earnings per share of USD 6.68, according to the company’s Investor Relations release. At Lang & Schwarz, the stock trades pre-market at EUR 618.70 at 8:12 a.m. CEST on October 22, 2026.

Third-quarter performance

The company said GAAP diluted earnings per share increased 9 percent to USD 4.64, while adjusted earnings per share rose 15 percent to USD 6.68. Organic revenue growth was 6 percent for the quarter ended September 26, 2026. GAAP operating income reached USD 2.26 billion, and adjusted operating income was USD 2.97 billion, the release said.

Pre-market indication

The latest indication is from Lang & Schwarz. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.

Business and market context

Thermo Fisher supplies laboratory technologies, analytical instruments, diagnostics, and pharmaceutical services. Its investor-relations materials describe products and services spanning life sciences research, laboratory productivity, diagnostics, and the development and manufacture of therapies. Market context: Market report S&P 500.

More news and analysis on Thermo Fisher Scientific stock

Disclaimer...
en | US8835561023 | THERMO FISHER SCIENTIFIC INC. | boerse | 70390609 | bgmi